InMode: New EmbraceRF Solution Introduces Subdermal Adipose Remodeling

Introducing the concept of Subdermal Adipose Remodeling, InMode Aesthetic Solutions is launching EmbraceRF to target the neck and face through a powerful combination of InMode’s proprietary technologies: FaceTite and Morpheus8. InMode says the new facial contouring solution address a treatment gap in current modalities offered to patients by introducing the concept of subdermal adipose remodeling of the face.

The EmbraceRF FaceTite procedure generates heat to “mold” the fat of the face in strategic positions in order to augment the jaw line and rejuvenate the neck. The combination of fat being left strategically behind to contour the face and neck is further augmented by InMode’s newly approved FDA Subdermal Adipose Remodeling Device (SARD): the Morpheus8. The Morpheus8 is applied externally. It is the first and only device to mold the fat subdermally in order to morph the aging facial features into a more youthful appearance. 

This new concept of facial rejuvenation is unique to EmbraceRF and can only be performed consistently and safely using the synergistic combination of FaceTite and Morpheus8, InMode says. 

The EmbraceRF now provides physicians and patients with the possibility to achieve surgical results in a 45 minute procedure under local anesthesia in the office. With only a down time of 48 hours, or a long weekend, patients can return to their daily activities in short time.